Answers are grounded in this paper and cite their sources.
of ≥150 ml/min remained at risk of empirical ceftriaxone underdosing. These data emphasize the need for therapeutic drug monitoring in ARC patients.
No takes yet. Share an insight, caveat, or question.
Ollivier et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: